India’s healthcare services segment continues to attract investor interest as private hospital chains expand capacity and deepen their presence across key regions. Riding this trend, Park Medi World Limited is coming out with its public issue in December 2025, giving investors an opportunity to participate in a fast-growing multi super speciality hospital network in North India.
Here is a detailed look at Park Medi World Ltd, its IPO structure, financials, and key business highlights.
About Park Medi World Ltd.
Incorporated in 2011, Park Medi World Limited operates a chain of private multi-super-speciality hospitals under the “Park” brand, primarily in North India. As of 31 March 2025, the company has a total bed capacity of 3,000 beds, making it the second largest chain of private hospitals in North India and the largest private hospital chain in Haryana.
Key highlights of the hospital network:
- Operates 14 multi-super-speciality hospitals under the Park brand
- All hospitals are NABH accredited, and eight are also NABL accredited
- Presence across Haryana, Delhi, Punjab, and Rajasthan
- As of 30 September 2025, the network has:
- 870 ICU beds
- 67 operating theatres (OTs)
- An oxygen generation plant at each location
The company offers more than 30 speciality and super speciality services, including internal medicine, neurology, urology, gastroenterology, general surgery, orthopaedics, and oncology.
Park Medi World has hospitals in:
- Haryana: Ambala, Gurugram, Karnal, Panipat, Palam Vihar, Sonipat, Faridabad
- Delhi
- Punjab: Patiala, Mohali
- Rajasthan: Jaipur, Behror
As of 30 September 2025, the company employs 1,014 doctors and 2,142 nurses, supporting its multi location healthcare operations.
Park Medi World IPO Details
Park Medi World IPO is a book-building issue aggregating up to ₹920.00 crore. The issue comprises a mix of fresh equity shares and an offer for sale.
Key IPO Details
| Particulars | Details |
| IPO Type | Bookbuilding IPO |
| IPO Date | 10 December 2025 to 12 December 2025 |
| Face Value | ₹2 per share |
| Price Band | ₹154 to ₹162 per share |
| Lot Size | 92 shares |
| Issue Size | 5,67,90,123 shares (₹920.00 crore) |
| Fresh Issue | 4,75,30,864 shares (₹770.00 crore) |
| Offer for Sale | 92,59,259 shares (₹150.00 crore) |
| Sale Type | Fresh Capital cum Offer for Sale |
| Listing At | BSE, NSE |
| Market Cap (Pre IPO) | ₹6,997.28 crore |
| Shareholding Pre Issue | 38,43,99,990 shares |
| Shareholding Post Issue | 43,19,30,854 shares |
Park Medi World IPO Timeline
| Event | Date |
| IPO Open Date | Wednesday, 10 December 2025 |
| IPO Close Date | Friday, 12 December 2025 |
| Basis of Allotment (Tentative) | Monday, 15 December 2025 |
| Initiation of Refunds | Tuesday, 16 December 2025 |
| Credit of Shares to Demat | Tuesday, 16 December 2025 |
| Listing Date (Tentative) | Wednesday, 17 December 2025 |
| Cut off time for UPI mandate confirmation | 5 PM on Friday, 12 December 2025 |
Park Medi World IPO Reservation
| Investor Category | Shares Offered |
| QIB | Not more than 50% of the Offer |
| Retail | Not less than 35% of the Offer |
| NII | Not less than 15% of the Offer |
Park Medi World IPO Lot Size
Investors can bid for a minimum of 92 shares and in multiples thereof.
| Application Category | Lots | Shares | Amount |
| Retail (Min) | 1 | 92 | ₹14,904 |
| Retail (Max) | 13 | 1,196 | ₹1,93,752 |
| S HNI (Min) | 14 | 1,288 | ₹2,08,656 |
| S HNI (Max) | 67 | 6,164 | ₹9,98,568 |
| B HNI (Min) | 68 | 6,256 | ₹10,13,472 |
Park Medi World Ltd. Financials
Park Medi World has reported steady growth in revenue and a sharp improvement in profitability over the last few years. For the period between FY 2024 and FY 2025, revenue grew by 13%, while profit after tax (PAT) increased by 40%.
Restated Consolidated Financial Information
All figures in ₹ crore
| Period Ended | 30 Sep 2025 | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
| Assets | 2,320.93 | 2,133.70 | 1,912.10 | 1,592.82 |
| Total Income | 823.39 | 1,425.97 | 1,263.08 | 1,272.18 |
| Profit After Tax | 139.14 | 213.22 | 152.01 | 228.19 |
| EBITDA | 217.14 | 372.17 | 310.30 | 390.34 |
| Net Worth | 1,153.05 | 1,021.86 | 815.98 | 667.55 |
| Reserves and Surplus | 1,187.77 | 1,049.40 | 858.63 | 653.09 |
| Total Borrowing | 733.91 | 682.07 | 686.71 | 575.68 |
Key Performance Indicators (KPI)
As of 31 March 2025
| KPI | Value |
| ROE | 20.68% |
| ROCE | 17.47% |
| Debt to Equity | 0.61 |
| RoNW | 20.08% |
| PAT Margin | 15.30% |
| EBITDA Margin | 26.71% |
| Price to Book Value | 6.09 |
| Promoter Holding Pre IPO | 95.55% |
| Promoter Holding Post IPO | 82.89% |
EPS & Evaluation
| Pre-IPO | Post-IPO | |
| EPS (₹) | 5.55 | 6.44 |
| P/E (x) | 29.21x | 25.14x |
The promoters of the company are Dr. Ajit Gupta and Dr. Ankit Gupta.
Park Medi World Ltd.: Business Overview and Competitive Strengths
Park Medi World Limited operates as a regional hospital platform with a strong presence in North India, focused on delivering quality healthcare at affordable prices.
Key business and competitive strengths include:
- Scale in North India:
The second-largest chain of private hospitals in North India and the largest private hospital chain in Haryana, with a bed capacity of 3,000 plus as of 31 March 2025. - Comprehensive speciality mix:
Offers more than 30 speciality and super speciality services such as internal medicine, neurology, urology, gastroenterology, general surgery, orthopaedics, and oncology, catering to diverse patient needs. - Accredited network and infrastructure:
All hospitals are NABH accredited, with eight also NABL accredited, indicating a strong focus on clinical quality and diagnostic standards. The network boasts 870 ICU beds, 67 OTs, and oxygen generation plants at all locations. - Geographical spread in high-demand locations:
Facilities across Haryana, Delhi, Punjab, and Rajasthan place the network in densely populated and growing urban and semi-urban regions. - Acquisition and integration track record:
The company has a history of acquiring stressed assets and turning them around, which has contributed to margin improvement in recent years. - Doctor-led professional management:
A doctor-driven leadership team with industry experience supports both clinical excellence and operational efficiency.
Objects of the Issue
The net proceeds from the Park Medi World IPO are proposed to be utilised for the following purposes:
| S. No. | Object of the Issue | Amount (₹ crore) |
| 1 | Repayment or prepayment, in full or in part, of certain outstanding borrowings availed by the Company and certain Subsidiaries | 380.00 |
| 2 | Funding capital expenditure for the development of a new hospital and expansion of an existing hospital by Subsidiaries Park Medicity (NCR) and Blue Heavens, respectively | 60.50 |
| 3 | Funding capital expenditure for the purchase of medical equipment by the Company and Subsidiaries Blue Heavens and Ratangiri | 27.46 |
| 4 | Unidentified inorganic acquisitions and general corporate purposes | Balance amount |
Park Medi World IPO: Peer Comparison
Park Medi World IPO can be compared with peers such as Apollo Hospitals Enterprise Ltd, Fortis Healthcare Ltd, Max Healthcare Institute Ltd, Narayana Hrudayalaya Ltd, and KIMS Hospitals. Reviewing these companies helps investors gauge Park Medi World’s position within the Indian hospital and healthcare services sector, offering a clearer understanding of its scale, operational strengths, and competitive standing before making informed investment decisions.
People Also Read:
- Edelweiss Silver ETF FoF NFO: A Precious Metals Opportunity for 2025
- Abakkus Liquid Fund NFO: A Short-Term, Low Volatility Investment Option for 2025
- Union Consumption Fund NFO: A Thematic Play on India’s Consumption Growth
- Axis Multi-Asset Active FoF NFO: A Dynamic Multi-Asset Strategy for 2025
- Mahindra Manulife Income Plus Arbitrage Active FOF NFO: A Moderately Balanced Approach for 2025
Conclusion
Park Medi World IPO offers investors exposure to a growing private hospital platform with:
- A sizeable and expanding bed capacity in North India
- Accredited multi-speciality hospitals across several key states
- Improving financial performance and healthy profitability metrics
- A strategy that combines organic expansion with acquisitions and capacity upgrades
At the same time, investors should be mindful of factors such as sector-level regulatory risks, high capital intensity, and the valuation level indicated by the stated price to book and price to earnings multiples. The issue appears fully priced based on recent financials and may suit investors with a medium to long-term investment view who are comfortable with the dynamics of the healthcare and hospital sector.
If you are exploring more investment opportunities, check out our dedicated page on upcoming IPO listings to stay updated on the latest market offerings.
